Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae
- PMID: 12183281
- PMCID: PMC127405
- DOI: 10.1128/AAC.46.9.3094-3095.2002
Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae
Abstract
The activity of AZD2563 against 250 highly resistant pneumococci and 267 drug-susceptible isolates was determined. The AZD2563 MICs for 50 and 90% of the strains tested were 1 and 2 micro g/ml and 0.5 and 1 micro g/ml, respectively, for the two isolate groups. These MICs were within 1 log(2) dilution of those of linezolid.
Figures
Similar articles
-
In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.J Antimicrob Chemother. 2002 Jul;50(1):89-93. doi: 10.1093/jac/dkf068. J Antimicrob Chemother. 2002. PMID: 12096011
-
In vitro activities of the oxazolidinone compounds linezolid (PNU-100766) and eperzolid (PNU-100592) against middle ear isolates of Streptococcus pneumoniae.Int J Antimicrob Agents. 1999 Jul;12(2):141-4. doi: 10.1016/s0924-8579(99)00059-x. Int J Antimicrob Agents. 1999. PMID: 10418759
-
In vivo pharmacodynamics of a new oxazolidinone (linezolid).Antimicrob Agents Chemother. 2002 Nov;46(11):3484-9. doi: 10.1128/AAC.46.11.3484-3489.2002. Antimicrob Agents Chemother. 2002. PMID: 12384354 Free PMC article.
-
Antimicrobial resistance to linezolid.Clin Infect Dis. 2004 Oct 1;39(7):1010-5. doi: 10.1086/423841. Epub 2004 Sep 10. Clin Infect Dis. 2004. PMID: 15472854 Review.
-
Biologically Active 2-Oxazolidinone Derivatives Beyond Antibacterial Activities.Curr Med Chem. 2023;30(23):2672-2689. doi: 10.2174/0929867329666220823113415. Curr Med Chem. 2023. PMID: 36017852 Review.
Cited by
-
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.Clin Microbiol Rev. 2021 Jun 16;34(3):e0018820. doi: 10.1128/CMR.00188-20. Epub 2021 Jun 2. Clin Microbiol Rev. 2021. PMID: 34076490 Free PMC article.
References
-
- Appelbaum, P. C. 2000. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 31(Suppl.):S29-S34. - PubMed
-
- Fines, M., and R. Leclercq. 2000. Activity of linezolid against gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors. J. Antimicrob. Chemother. 45:797-802. - PubMed
-
- Friedland, I. R., and G. H. McCracken. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical